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Abstract
Objective—The etiology of knee osteoarthritis (OA), the most common form of arthritis, is 
complex and may differ by race or ethnicity. In recent years, genetic studies have identified 
multiple genetic variants associated with OA, but nearly all were conducted in European 
Caucasian and Asian Americans. Few studies have focused on genetics of knee OA in African 
Americans.
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Methods—We performed a genome-wide association study of radiographic knee OA in 1,217 
African Americans from two North American cohort studies: 590 subjects from the Johnston 
County Osteoarthritis Project and 627 subjects from the Osteoarthritis Initiative. Analyses were 
conducted in each cohort separately and combined in an inverse variance fixed effects meta-
analysis, which were then included in pathway analyses. We additionally tested 12 SNPs robustly 
associated with OA in European Caucasian populations for association in African Americans.
Results—We identified a genome-wide significant variant in LINC01006 (minor allele 
frequency=12%, p-value=4.11×10−9) that is less common in European Caucasian populations 
(minor allele frequency < 3%). Five other independent loci reached suggestive significance (p-
value < 1×10−6). In pathway analyses, dorsal/ventral neural tube patterning and iron ion transport 
pathways were significantly associated with knee OA in African Americans (FDR < 0.05). We 
found no evidence that previously reported OA susceptibility variants in European Caucasians 
were associated with knee OA in African Americans.
Conclusion—These results highlight differences in the genetic architecture of knee OA between 
African American and European Caucasians, which underscores the need to include more diverse 
populations in OA genetics studies.
Introduction
Osteoarthritis (OA) is a multifactorial joint disease characterized by cartilage degradation 
and structural changes in the subchondral bone, which often leads to joint pain, activity 
limitations and physical disability. The etiopathogenesis of OA is complex; family studies 
indicate that at least part of OA susceptibility is under genetic control (1). The heritability of 
radiographic knee OA has been estimated in twin studies to be 39% (2). Knee OA is also 
strongly influenced by environmental factors, such as history of injuries and overweight, 
making it difficult to identify the genetic mechanisms behind knee OA pathogenesis (3). 
Identifying genes underlying OA susceptibility is important insofar as the implicated genes 
may reveal insights into disease pathogenesis and identify potential targets for prevention or 
therapy. At least a dozen robustly replicated OA susceptibility variants have been identified 
to date; most of these association studies have been carried out in European Caucasians (4–
12).
Studies focused on African Americans are important because African Americans experience 
a higher prevalence of knee OA (13) than Caucasian Americans and there is disparity in the 
incidence of total knee arthroplasty for knee OA with higher rates in Caucasian Americans 
than African Americans (14). It is currently unknown whether these differences are due to 
biological or sociocultural differences or both. The goals of this report are two-fold: first, to 
identify SNPs associated with radiographic knee OA in African Americans through a 
genome-wide association analysis, and second, to determine whether SNPs robustly 
associated with OA in European Caucasian populations are also associated with 
radiographic knee OA in African Americans. To address these goals, we performed 
association analyses in two large population-based studies of knee OA that included 
substantial numbers of African Americans.
Liu et al. Page 2
J Rheumatol. Author manuscript; available in PMC 2018 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Methods
The analyses presented are based on African American participants of the Johnston County 
Osteoarthritis Project (JoCo) and the Osteoarthritis Initiative (OAI).
JoCo is an ongoing, community-based cohort study of knee and hip OA in individuals 45 
years and older recruited from Johnston County, North Carolina. The original participants 
were enrolled between 1990 and 1997 (13), with additional participants recruited between 
2003 and 2004. Participants were recruited by probability sampling, with oversampling of 
African Americans, where Caucasians and African Americans represent 68% and 32% of 
the cohort, respectively. The age of the participants ranged from 45 to 98 years; two-thirds of 
the participants were women. Additional study details have been previously described (13). 
JoCo has been continuously approved by institutional review boards (IRB) at the University 
of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention, and all 
participants gave informed consent (IRB approval number, 92-0583). A total of 590 African 
Americans with radiographic readings for knee OA were genotyped and included in this 
study.
The Osteoarthritis Initiative (OAI) is a longitudinal, natural history study of knee OA in 
middle aged and older individuals who were either at risk for, or have, symptomatic 
radiographic knee OA. A total of 4,796 subjects aged 45–79 years were enrolled at four 
clinical centers (Baltimore, MD; Columbus, OH; Pittsburgh, PA; and Providence, RI), 
received a baseline evaluation between 2004 and 2006, and were invited back to assess 
incidence or progression of OA annually for up to eight years. The study was approved by 
the IRB at each clinical center. All participants provided informed consent. The OAI study 
and public use of clinical and imaging data used in this study were approved by the 
committee on Human Research at the University of California, San Francisco (IRB approval 
number, 10-00532). The current analysis was restricted to 627 African Americans with 
genotype data and in whom knee radiographic readings, read by consensus, were available 
from radiographs obtained at the baseline evaluation. Study details and data are publicly 
available on the OAI web site (http://oai.epi-ucsf.org/datarelease/docs/
StudyDesignProtocol.pdf).
Radiographic knee OA cases were defined similarly in both studies as having definite 
osteophytes and possible joint space narrowing (Kellgren-Lawrence [KL] grade ≥ 2) or total 
joint replacement in one or both knees. Controls were defined as having in both knees no or 
doubtful evidence for OA (KL grade = 0 or 1).
Genotyping was performed on the Illumina Infinium 1M-Duo bead array and Illumina 
Omni-Quad 2.5M array for JoCo and OAI, respectively. Genotypes were called within each 
study using the Illumina BeadStudio software. Sample level quality control (QC) included 
removal of samples with below threshold sample call rates (< 0.99 for JoCo and < 0.95 for 
OAI), samples showing excess evidence for heterozygosity, and samples whose reported 
gender did not match their sex assignment based on genotype data. Single nucleotide 
polymorphisms (SNPs) with missing call rate > 0.01 were excluded. We additionally 
eliminated samples showing evidence for cryptic relatedness based on genetic data and 
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SNPs showing evidence for extreme deviation from Hardy-Weinberg equilibrium (p-value < 
1×10−6).
In JoCo and OAI separately, we imputed SNP dosages in all samples based on the 1000 
genomes Caucasian and African American reference panel (June 2011 release). Imputation 
for both studies was conducted using Minimac (http://genome.sph.umich.edu/wiki/
Minimac). Following imputation, 8.38 million SNPs were available for analysis in JoCo and 
OAI.
First, we performed a genome-wide association meta-analysis of the combined JoCo and 
OAI sample to identify novel SNPs associated with radiographic knee OA in African 
Americans. Prior to the genetic association analysis, principal components analysis was 
performed in each study to assess population substructure. Principal components that were 
significantly associated with the outcome (p-value < 0.05) were used as covariates in 
association analyses. We tested each SNP for association with radiographic knee OA within 
JoCo and OAI separately. We used logistic regression, assuming an additive genetic model, 
with adjustment for age, sex, and principal components. We additionally adjusted for body 
mass index (BMI) in secondary analyses. Association analyses for the JoCo and OAI were 
performed with ProbABEL and PLINK, respectively. Beta estimates were then combined 
across studies weighting the study specific estimates by the inverse of their variances using 
the METAL software program (15). Based on a combined sample size of 742 cases and 475 
controls, we had 80% power to detect odds ratios of 1.51–1.65 for SNPs having minor allele 
frequencies (MAF) ranging from 0.10–0.50 at genome-wide thresholds for statistical 
significance (p-value = 5×10−8). Heterogeneity between studies was assessed using 
Cochran’s Q statistic. We generated LocusZoom plots to visualize and provide genomic 
context to top meta-analysis findings (p-value < 1×10−6) (16).
Given the limited power to detect associations at individual SNPs, we conducted pathway 
analyses with MAGENTA (Meta-Analysis Gene-set Enrichment of variant Associations), 
which can be downloaded from the Broad Institute website (http://
www.broadinstitute.org/mpg/magenta/). Pathway analyses were based on meta-analysis SNP 
p-values and all databases available in MAGENTA, including Gene Ontology, Ingenuity, 
KEGG and PANTHER. We set the threshold for significance at False Discovery Rate (FDR) 
< 0.05.
Second, we tested whether SNPs previously associated with OA in European Caucasian 
populations were also associated with radiographic knee OA in African Americans. We 
selected for replication 12 SNPs associated with knee OA at genome-wide levels of 
significance or near genome-wide significance in prior genome-wide association studies 
(GWAS) (8–12). In addition, we calculated the power to detect the association of each SNP 
with radiographic knee OA in our African American sample based on the odds ratio reported 
from the literature and the allele frequency of that SNP observed in African Americans 
(Table 4).
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Results
Sample characteristics of the 1,217 African American subjects included in this analysis (742 
cases and 475 controls) are provided in Table 1. Compared to controls, cases were older, had 
higher BMI, and were more likely to be female. Approximately 50% of JoCo study subjects 
were cases compared to 72% of OAI study subjects. The larger number of cases than 
controls in OAI can be attributed to that study’s inclusion criteria, which were designed to 
enrich the cohort with subjects who had symptomatic radiographic knee OA.
We performed a genome-wide association analysis of radiographic knee OA to identify 
novel associations in African Americans. Based on the relatively small sample size, we 
regard these analyses as exploratory. The genomic inflation factor, λ, was 0.954 for the 
combined meta-analysis, providing no evidence for inflation of p-values. As shown in the 
meta-analysis GWAS results (Figure 1), one locus in LINC01006, a long intergenic non-
protein coding RNA on chromosome 7, reached genome-wide significance in the primary 
meta-analysis (rs7792864, MAF=12%, OR [95% CI]=2.35 [1.77–3.13], p-
value=4.11×10−9). Five other independent loci were associated with knee OA at p-values 
less than 1×10−6. These loci are located in or near MAGI1 (rs145965284, MAF=27%), 
ANKRD6 (rs78571182, MAF=12%), EPPK1/PLEC (rs76983122, MAF=11%), PAX7/
TAS1R2 (rs4920343, MAF=13%), and DDX10/C11orf87 (rs9783397, MAF=29%); odds 
ratios ranged from 1.83 to 2.08 (Table 2). Regional association plots showed strong 
supporting signals in high linkage disequilibrium with rs7792864 (LINC01006) and 
rs76983122 (EPPK1/PLEC), but not rs78571182 (ANKRD6) (Figure 2). The reliability of 
the signal for rs145965284 (MAGI1) and rs9783397 (DDX10/C11orf87) was unclear due to 
lack of linkage disequilibrium data with other SNPs. After additional adjustment for BMI, 
odds ratios were slightly attenuated for associations in LINC01006, MAGI1, EPPK1/PLEC, 
and PAX7/TAS1R2, but not ANKRD6 or DDX10/C11orf87 (Table 2). P-values for 
heterogeneity ranged from 0.17 to 0.71, providing little evidence that there was significant 
heterogeneity between studies. In pathway analyses, we identified two pathways associated 
with knee OA that reached statistical significance (FDR < 0.05): 1) dorsal/ventral neural 
tube patterning and 2) iron ion transport (Table 3).
Following the genome-wide association analysis, we attempted to replicate 12 SNPs 
previously identified to be robustly associated with OA, including 3 SNPs associated with 
knee OA (9–12) and 9 genome-wide or near genome-wide significant SNPs identified by the 
arcOGEN (Arthritis Research Council Osteoarthritis Genetics) study, the largest GWAS of 
OA in European Caucasians to date (8). Risk allele frequencies were lower in African 
Americans than European Caucasians for most SNPs (chromosome 7q22, GDF5, MCF2L, 
GLT8D1, GNL3, KLHDC5/PTHLH, and TP63). We did not test SNPs in chromosome 7q22 
or KLHDC5/PTHLH due to minor allele frequencies less than 1%. Of the remaining 10 
SNPs, none was significantly associated with knee OA in African Americans (Table 4). 
Power to detect significant associations of the same magnitude as seen in European 
Caucasians at p-value < 0.05 ranged from 32% to 90%. Power to detect nominal associations 
was greater than 80% for only one locus, TP63.
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Discussion
This GWAS meta-analysis is the first genome-wide effort to identify genetic polymorphisms 
associated with knee OA in African Americans. We identified one genome-wide significant 
locus in LINC01006 and five loci that reached suggestive significance.
Pathway analyses suggested that dorsal/ventral neural tube patterning and iron ion transport 
pathways may be associated with knee OA in African Americans. However, we found little 
evidence that previously reported OA susceptibility variants in European Caucasians were 
associated with knee OA in African Americans. This suggests that the genetic architecture of 
knee OA in African Americans may be different from European Caucasians, warranting 
future genetic studies of knee OA in populations with African ancestry.
We identified a novel genome-wide significant locus in LINC01006, a long intergenic non-
protein coding RNA located on chromosome 7q36 near INSIG2, SHH, C70rf13, RNF32, 
and LMBR1. The function of LINC01006 is not entirely clear, but it is increasingly 
appreciated that long intergenic non-protein coding RNAs may play key regulatory roles in 
gene expression, particularly among nearby genes (17). The locus on chromosome 7q36 has 
been linked to preaxial polydactyly and other limb disorders, highlighting the possibility that 
genes and regulatory elements found in this region are related to limb development (18–20). 
The chromosome 7q36 locus has also been implicated in genetic linkage studies of BMI (21, 
22). In this GWAS, adjustment for BMI attenuated the association between LINC01006 
variants and knee OA, suggesting that this locus could act in part through body weight 
regulation. Since overweight and obesity are highly prevalent in African Americans and also 
strong risk factors for knee OA (23, 24), it is possible that some knee OA loci discovered in 
African Americans may operate through their effects on BMI. After adjusting for BMI, most 
top loci had attenuated effects and no locus reached genome-wide significance.
None of the candidate SNPs that have been robustly associated with OA in prior studies of 
European Caucasian populations was replicated in this study of African Americans. The 
most likely reason for lack of replication is the relatively low power of our sample – even 
comprising 742 carefully phenotyped cases – to detect SNPs having relatively modest effect 
sizes (i.e., odds ratios ranging from 1.11 to 1.21). While the small sample size of our study 
limited ability to detect significant p-values, effect size that is independent from sample size 
may still be a good representation of the magnitude of effect on knee OA. Notably, the two 
loci for which power was sufficient for detecting an association (79% power for the risk 
allele in ASTN2 and 90% power for the risk allele in TP63), both had effect sizes consistent 
with that found in European Caucasians (odds ratios of 1.11 and 1.12, respectively). The 
odds ratios for other candidate loci, including GDF5, MCF2L, GLT8D1, GNL3, FILIP1/
SENP6, CHST11, FTO, and SUPT3H/CDC5L were largely null and inconsistent with effect 
sizes identified in European Caucasians. The lack of robust replication could be a 
consequence of low power and/or heterogeneity in the JoCo and OAI populations, or 
indicate a difference in the genetic architecture of OA between African Americans and 
European Caucasians.
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There may be differences in the underlying linkage disequilibrium structure between African 
and European populations that may alter the degree to which the tested SNPs tag the 
unmeasured pathogenic variant that is responsible for OA. Risk allele frequencies for 10 of 
12 OA candidate SNPs were noticeably different between ethnic groups, including 7 SNPs 
that had lower frequencies and 3 SNPs that had higher frequencies in African Americans 
compared to Caucasians. The genome-wide significant variant that we identified in 
LINC01006 had a minor allele frequency of 12% in African Americans and was much less 
common in European Caucasian populations, where the minor allele frequency was less than 
3%. Similarly, allele frequencies for other top findings were noticeably different between 
African Americans and European Caucasians. None of the top African American GWAS 
loci was associated with knee OA in our previous report of genetic associations in 
Caucasians (25).
It is also possible that the etiology of OA may be slightly different across ethnic groups. For 
example, African Americans experience a higher prevalence of knee OA (13), greater lateral 
tibiofemoral joint space narrowing, greater valgus thrust, and more pain than Caucasian 
Americans, which may be due to either biological or sociocultural differences, or both. 
However, African-Americans are less likely than Caucasian Americans to undergo total knee 
arthroplasty (14).
We had limited power to detect genome-wide significant loci given the small sample size, 
requiring odds ratios ranging from 1.51–1.65 in order to obtain significant associations in 
the GWAS; this is a much larger effect size than reported for all prior detected associations 
in European Caucasians. Effect sizes for all genome-wide significant and suggestive loci in 
this study were larger than 1.83, exceeding the minimum effect size needed to claim 
statistical significance with 80% power. This demonstrates an inherent bias in our study. We 
are more likely to identify variants with large effect sizes than modest effect sizes. It is 
possible that our top findings may actually have modest effects and by chance have 
detectable large effects in JoCo and OAI. Because of this, future replication of these 
associations in other cohorts will be essential. This phenomenon of the “winner’s curse” 
occurs often in GWAS and underscores the need to include even larger studies of knee OA in 
African Americans to replicate and refine genetic associations.
A strength of our study was the standardized and careful phenotyping of radiographic knee 
OA used in both JoCo and OAI. However, such assessments are costly and time-consuming 
to obtain, making it difficult to accrue the very large sample sizes needed for genetic 
association studies. Despite these difficulties, there is great scientific value to including non-
European populations in genetic studies because associations with novel loci not previously 
detected in Europeans can sometimes be uncovered due to differences in allele frequencies 
between European and non-European populations or to differences in linkage disequilibrium 
structure. Association testing at established loci in populations representing different ethnic 
groups may also be useful in efforts to identify the causative variant. Even larger studies of 
OA genetics in African Americans are needed and have the potential to provide insight into 
disparities in OA prevalence and etiology. We invite other researchers to contribute 
additional samples to a larger scale meta-analysis of OA in under-represented populations.
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In summary, we conducted an exploratory GWAS meta-analysis study of radiographic knee 
OA in African Americans in two of the largest, well-characterized OA cohorts. We identified 
a genome-wide significant finding in LINC01006 and significant pathways in dorsal/ventral 
neural tube patterning and iron ion transport, but did not replicate associations with SNPs 
previously associated with OA in European populations possibly due to lack of power. These 
results highlight the importance of including non-European ancestry populations in studies 
of OA genetics.
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Figure 1. 
Manhattan plot of the knee OA GWAS meta-analysis in African Americans. The horizontal 
line represents the threshold for genome-wide significance, p-value < 5×10−8.
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Figure 2. 
LocusZoom plots for top genetic associations with knee OA. –Log10 of the p-values are 
plotted against the genetic position (hg19) along the chromosome. Colored points represent 
the degree of linkage disequilibrium (r2) between the lead SNP (in purple) and all other 
SNPs in the region. Panels A-E are LocusZoom plots for LINC01006, MAGI1, ANKRD6, 
EPPK1/PLEC, PAX7/TAS1R2, and DDX10/C11orf87, respectively.
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